AZLOCILLIN PHARMACOKINETICS IN PATIENTS WITH CYSTIC-FIBROSIS

被引:16
作者
BOSSO, JA
SAXON, BA
HERBST, JJ
MATSEN, JM
机构
[1] UNIV UTAH, SCH MED, DEPT PEDIAT, SALT LAKE CITY, UT 84112 USA
[2] UNIV UTAH, SCH MED, DEPT PATHOL, SALT LAKE CITY, UT 84112 USA
关键词
D O I
10.1128/AAC.25.5.630
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:630 / 632
页数:3
相关论文
共 12 条
[1]   SIMPLIFIED ACCURATE METHOD FOR ANTIBIOTIC ASSAY OF CLINICAL SPECIMENS [J].
BENNETT, JV ;
BRODIE, JL ;
BENNER, EJ ;
KIRBY, WMM .
APPLIED MICROBIOLOGY, 1966, 14 (02) :170-&
[2]   DOSE-DEPENDENT PHARMACOKINETICS OF AZLOCILLIN COMPARED TO MEZLOCILLIN [J].
BERGAN, T ;
THORSTEINSSON, SB ;
STEINGRIMSSON, O .
CHEMOTHERAPY, 1982, 28 (03) :160-170
[3]  
BERGAN T, 1981, SCAND J INFECT DIS, P33
[4]  
JUSKO WJ, 1975, PEDIATRICS, V56, P1038
[5]  
KEARNS GL, 1982, J PEDIATR-US, V100, P312, DOI 10.1016/S0022-3476(82)80663-X
[6]   PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS [J].
KELLY, HB ;
MENENDEZ, R ;
FAN, L ;
MURPHY, S .
JOURNAL OF PEDIATRICS, 1982, 100 (02) :318-321
[8]   PHARMACOKINETICS OF NETILMICIN IN CHILDREN WITH AND WITHOUT CYSTIC-FIBROSIS [J].
MICHALSEN, H ;
BERGAN, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (06) :1029-1031
[9]  
MICHALSEN H, 1982, ACTA PAEDIATR SCAND, P101
[10]  
MOLLER NE, 1982, EUR J RESPIR DIS, V63, P130